Comprehensive assessment of markers of systemic inflammation and activation of immunity in HIV-positive patients receiving antiretroviral therapy
Main Authors: | A. Matuzkova, N. Pshenichnaya, A. Suladze, L. Dosyagaeva, T. Tverdokhlebova, A. Zhuravlev |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220314594 |
Similar Items
-
ACTUAL ISSUES IN HIV INFECTION AND PREVENTION OF PERINATAL HIV TRANSMISSION IN THE SOUTH OF RUSSIA
by: A. N. Matuzkova, et al.
Published: (2018-10-01) -
Surveillance for molecular and biological properties of HIV strains
by: D. Kolpakov, et al.
Published: (2022-03-01) -
COVID-19 in People Living with HIV
by: N. Dolgova, et al.
Published: (2022-03-01) -
Evaluation of the ELISA and immune blotting value for the diagnosis of echinococcosis
by: L. Ermakova, et al.
Published: (2020-12-01) -
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
by: Rajesh T Gandhi, et al.
Published: (2017-04-01)